RBC Bioscience (ROCO:6848) Total Payout Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6848 RBC Bioscience Corp ROCO:6848
75 GF Score
Price NT$20.55
GF Value NT$18.24
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is RBC Bioscience Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

RBC Bioscience's current Total Payout Ratio is .

RBC Bioscience Total Payout Ratio Related Terms

RBC Bioscience Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for RBC Bioscience's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience Total Payout Ratio Chart

RBC Bioscience Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Ratio
Get a 7-Day Free Trial - - - - -

RBC Bioscience Semi-Annual Data
Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ROCO:6848 vs VRTX, REGN, MRNA: Total Payout Ratio Comparison

For the Biotechnology subindustry, RBC Bioscience's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Bioscience Total Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's Total Payout Ratio falls into.


ROCO:6848
75GF Score
RBC Bioscience Corp ROCO:6848
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RBC Bioscience Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

RBC Bioscience's Total Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 0 + -4.282) / 23.543
=0.18

RBC Bioscience's Total Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 0 + -0) / 8.684
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is RBC Bioscience (ROCO:6848) Overvalued in 2026?

Based on GuruFocus' analysis, RBC Bioscience stock appears to be overvalued. The current stock price of NT$20.55 is trading 12.7% above its estimated GF Value™ of NT$18.24. GuruFocus considers RBC Bioscience to be Modestly Overvalued.

Key valuation signals for ROCO:6848:

  • Total Payout Ratio:
  • GF Value™: NT$18.24 vs. price of NT$20.55 (12.7% above fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the ROCO:6848 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RBC Bioscience Business Description

Address No. 15, Qiaohe Road, 15th Floor, Zhonghe District, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.
75GF Score

Get the complete analysis for ROCO:6848

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.55
Price
NT$18.24
GF Value